title: Early Dementia Screening.
abstract: As the population of the world increases, there will be larger numbers of people with dementia and an emerging need for prompt diagnosis and treatment. Early dementia screening is the process by which a patient who might be in the prodromal phases of a dementing illness is determined as having, or not having, the hallmarks of a neurodegenerative condition. The concepts of mild cognitive impairment, or mild neurocognitive disorder, are useful in analyzing the patient in the prodromal phase of a dementing disease; however, the transformation to dementia may be as low as 10% per annum. The search for early dementia requires a comprehensive clinical evaluation, cognitive assessment, determination of functional status, corroborative history and imaging (including MRI, FDG-PET and maybe amyloid PET), cerebrospinal fluid (CSF) examination assaying Aβ1-42, T-τ and P-τ might also be helpful. Primary care physicians are fundamental in the screening process and are vital in initiating specialist investigation and treatment. Early dementia screening is especially important in an age where there is a search for disease modifying therapies, where there is mounting evidence that treatment, if given early, might influence the natural history-hence the need for cost-effective screening measures for early dementia.
authors.affiliation: Neurodegenerative Disorders Research Pty Ltd, 4 Lawrence Avenue, West Perth 6005, Western Australia, Australia. research@ndr.org.au.
authors.forename: Peter K
authors.initials: PK
authors.lastname: Panegyres
authors.affiliation: Neurodegenerative Disorders Research Pty Ltd, 4 Lawrence Avenue, West Perth 6005, Western Australia, Australia. renee.berry1@my.nd.edu.au.
authors.forename: Renee
authors.initials: R
authors.lastname: Berry
authors.affiliation: Neurodegenerative Disorders Research Pty Ltd, 4 Lawrence Avenue, West Perth 6005, Western Australia, Australia. jen.burchell@gmail.com.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Burchell
keywords: Alzheimer’s disease; Solanezumab; amnestic mild cognitive impairment; clinical dementia rating scale; cognitive testing; global deterioration scale; mild cognitive impairment; mild neurocognitive disorder; non-amnestic mild cognitive impairment; treatments
references.citation: Am J Neurodegener Dis. 2014 Dec 05;3(3):143-51
references.pmid: 25628965
references.citation: JAMA. 1987 Mar 20;257(11):1492-5
references.pmid: 3820464
references.citation: Clin Pharmacol Ther. 2001 Mar;69(3):89-95
references.pmid: 11240971
references.citation: Am J Psychiatry. 1982 Sep;139(9):1136-9
references.pmid: 7114305
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):705-12
references.pmid: 12188103
references.citation: JAMA Neurol. 2013 Sep 1;70(9):1158-66
references.pmid: 23835471
references.citation: J Neurol Neurosurg Psychiatry. 2010 May;81(5):541-6
references.pmid: 19965857
references.citation: BMJ Open. 2012 Oct 10;2(5):null
references.pmid: 23059847
references.citation: Int J Clin Pract. 2012 Feb;66(2):185-98
references.pmid: 22257044
references.citation: Aging Ment Health. 2004 Mar;8(2):99-105
references.pmid: 14982713
references.citation: J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):692-8
references.pmid: 24133287
references.citation: Arch Neurol. 1996 May;53(5):423-7
references.pmid: 8624217
references.citation: Br J Psychiatry. 2002 May;180:411-5
references.pmid: 11983637
references.citation: Neurology. 2001 May 8;56(9):1143-53
references.pmid: 11342678
references.citation: J Am Geriatr Soc. 1995 Jul;43(7):741-6
references.pmid: 7602023
references.citation: Lancet Neurol. 2014 Jun;13(6):614-29
references.pmid: 24849862
references.citation: Int Psychogeriatr. 2008 Oct;20(5):911-26
references.pmid: 18533066
references.citation: Int J Geriatr Psychiatry. 2014 Jun;29(6):551-61
references.pmid: 24123413
references.citation: Alzheimers Dement. 2012 Jul;8(4):261-71
references.pmid: 22672770
references.citation: N Engl J Med. 2014 Jan 23;370(4):311-21
references.pmid: 24450890
references.citation: Arch Neurol. 1999 Mar;56(3):303-8
references.pmid: 10190820
references.citation: Alzheimer Dis Assoc Disord. 2004 Oct-Dec;18(4):219-22
references.pmid: 15592134
references.citation: Arch Neurol. 2009 Dec;66(12):1447-55
references.pmid: 20008648
references.citation: J Neurosci. 2010 Oct 13;30(41):13861-6
references.pmid: 20943926
references.citation: Ont Health Technol Assess Ser. 2014 Feb 01;14(1):1-64
references.pmid: 24592296
references.citation: J Psychiatr Res. 1975 Nov;12(3):189-98
references.pmid: 1202204
references.citation: Expert Opin Biol Ther. 2014 Oct;14(10):1465-76
references.pmid: 24981190
references.citation: Lancet Neurol. 2007 Aug;6(8):734-46
references.pmid: 17616482
references.citation: Neurology. 2009 Sep 8;73(10 ):754-60
references.pmid: 19587325
references.citation: J Alzheimers Dis. 2011;26(4):627-45
references.pmid: 21694448
references.citation: Dialogues Clin Neurosci. 2004 Dec;6(4):401-8
references.pmid: 22034212
references.citation: Acta Psychiatr Scand. 2006 Aug;114(2):75-90
references.pmid: 16836595
references.citation: J Intern Med. 2004 Sep;256(3):183-94
references.pmid: 15324362
references.citation: Eur Arch Psychiatry Clin Neurosci. 2013 Oct;263(7):539-52
references.pmid: 23917803
references.citation: BMC Neurol. 2012 Jun 06;12:33
references.pmid: 22672344
references.citation: Ann Neurol. 2013 Apr;73(4):A7-9
references.pmid: 24643982
references.citation: Arch Neurol. 1990 Nov;47(11):1189-93
references.pmid: 2241616
references.citation: Curr Opin Psychiatry. 2011 May;24(3):237-42
references.pmid: 21346570
references.citation: Am J Geriatr Psychiatry. 2015 Aug;23 (8):768-79
references.pmid: 25728011
references.citation: Dement Geriatr Cogn Disord. 2004;18(1):50-4
references.pmid: 15084794
references.citation: Alzheimers Dement. 2011 May;7(3):270-9
references.pmid: 21514249
references.citation: Brain Inj. 2003 Aug;17(8):643-51
references.pmid: 12850949
references.citation: J Am Geriatr Soc. 2000 May;48(5):558-9
references.pmid: 10811551
references.citation: Biochemistry. 1993 May 11;32(18):4693-7
references.pmid: 8490014
references.citation: Brain. 2010 Nov;133(11):3290-300
references.pmid: 20823087
references.citation: Clin Geriatr Med. 2013 Nov;29(4):791-807
references.pmid: 24094297
references.citation: Br J Psychiatry. 2013 Sep;203(3):255-64
references.pmid: 24085737
references.citation: JAMA. 1997 Oct 22-29;278(16):1363-71
references.pmid: 9343469
references.citation: Br J Psychiatry. 1982 Jun;140:566-72
references.pmid: 7104545
references.citation: Am J Geriatr Psychiatry. 2008 Mar;16(3):220-8
references.pmid: 18310552
references.citation: J Intern Med. 2004 Sep;256(3):240-6
references.pmid: 15324367
references.citation: Alzheimer Dis Assoc Disord. 2010 Oct-Dec;24(4):348-53
references.pmid: 20592580
references.citation: Alzheimers Dement. 2011 May;7(3):280-92
references.pmid: 21514248
references.citation: Neurology. 2004 Jul 13;63(1):115-21
references.pmid: 15249620
references.citation: Neurology. 1984 Jul;34(7):939-44
references.pmid: 6610841
references.citation: J Psychiatr Res. 1982-1983;17(1):37-49
references.pmid: 7183759
references.citation: Clin Neuropharmacol. 2010 Mar-Apr;33(2):67-73
references.pmid: 20375655
references.citation: Neurol Sci. 2006 Mar;27 Suppl 1:S24-6
references.pmid: 16708177
references.citation: Arch Neurol. 2009 Sep;66(9):1151-7
references.pmid: 19752306